ihuman institute
One Receptor, Two Disparate Binding Sites
The unusual dual binding sites of the GPCR P2Y1R could lead to new blood clotting drugs.
Amgen China R&D Center To Open On ShanghaiTech Campus
Amgen will open a China research and development center at ShanghaiTech University in 2014.